MedPath

Effect of donepezil on the onset and duration time of neuromuscular blocking agent

Not Applicable
Conditions
Diseases of the nervous system
Registration Number
KCT0005979
Lead Sponsor
Chonnam National University Hospital Hwasun Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients scheduled to undergo elective surgery under general anesthesia at Hwasun Chonnam National University Hospital;
- Patients taking Donnefezil due to dementia (Patient group)
- Patients with no history of taking Donnepzil (control group)

Exclusion Criteria

-Paitents with history of drug and other hypersensitivity reactions
-Patients with significant neuromuscular disease or problems
-Patients with significant renal or liver disease
-Patients who require rapid sequence induction
-Patients taking medication with potential to affect the neuromuscular transmission system;
-Other patients deemed inappropriate by the researcher

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time from injetion of rocuronium to zero TOF count
Secondary Outcome Measures
NameTimeMethod
Time from injetion of rocuronium to one TOF count (for 3 consecutive times);Time from injetion of rocuronium to four TOF count (for 3 consecutive times)
© Copyright 2025. All Rights Reserved by MedPath